Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Metabolic complications and increased cardiovascular risks as a result of androgen deprivation therapy in men with prostate cancer.

Shastri BR, Yaturu S.

Prostate Cancer. 2011;2011:391576. doi: 10.1155/2011/391576. Epub 2011 Aug 1.

PMID:
22110984
[PubMed]
Free PMC Article
2.

Risk stratification in the hormonal treatment of patients with prostate cancer.

Uhlman MA, Moul JW, Tang P, Stackhouse DA, Sun L.

Ther Adv Med Oncol. 2009 Sep;1(2):79-94. doi: 10.1177/1758834009340164.

PMID:
21789114
[PubMed]
Free PMC Article
3.

Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art.

Milecki P, Martenka P, Antczak A, Kwias Z.

Cancer Manag Res. 2010 Oct 11;2:243-53. doi: 10.2147/CMR.S8912.

PMID:
21188116
[PubMed]
Free PMC Article
4.

Novel diagnostic biomarkers for prostate cancer.

Madu CO, Lu Y.

J Cancer. 2010 Oct 6;1:150-77.

PMID:
20975847
[PubMed]
Free PMC Article
5.

Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and Progression.

Singh RK, Sudhakar A, Lokeshwar BL.

J Cancer Sci Ther. 2010;2(4):89-94.

PMID:
20808724
[PubMed]
Free PMC Article
6.

Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues.

Bagrodia A, Diblasio CJ, Wake RW, Derweesh IH.

Indian J Urol. 2009 Apr;25(2):169-76. doi: 10.4103/0970-1591.52907.

PMID:
19672340
[PubMed]
Free PMC Article
7.

Mortality results from a randomized prostate-cancer screening trial.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.

N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18. Erratum in: N Engl J Med. 2009 Apr 23;360(17):1797.

PMID:
19297565
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Management of complications of androgen deprivation therapy in the older man.

Mohile SG, Mustian K, Bylow K, Hall W, Dale W.

Crit Rev Oncol Hematol. 2009 Jun;70(3):235-55. doi: 10.1016/j.critrevonc.2008.09.004. Epub 2008 Oct 25. Review.

PMID:
18952456
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Adami HO, Johansson JE; Scandinavian Prostate Cancer Group Study Number 4.

J Natl Cancer Inst. 2008 Aug 20;100(16):1144-54. doi: 10.1093/jnci/djn255. Epub 2008 Aug 11.

PMID:
18695132
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study.

Barry MJ, Delorenzo MA, Walker-Corkery ES, Lucas FL, Wennberg DC.

BJU Int. 2006 Nov;98(5):973-8. Epub 2006 Jul 28.

PMID:
16879443
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk